Waldheim Pharmazeutika

Waldheim Pharmazeutika is an Austrian pharmaceutical company based in Vienna, specializing in the development, production, and distribution of specialty pharmaceuticals and diagnostic agents. Founded in 1895, the company has a long-standing reputation in the Austrian healthcare market, particularly in the fields of dermatology, neurology, and radiology. Waldheim is notably recognized for its product Scabioral, an oral treatment for scabies that serves as a key therapeutic option in several European markets. In 2001, the company was acquired by Sanochemia Pharmazeutika, which allowed for expanded manufacturing capabilities and a broader international reach. Today, Waldheim continues to operate as a specialty pharma provider, focusing on niche indications and high-quality generic medications.